Table 2.
Biological characteristics at onset of the 8 newly reported patients.
| Pt #1 | Pt #2 | Pt #3 | Pt #4 | Pt #5 | Pt #6 | Pt #7 | Pt #8 | |
|---|---|---|---|---|---|---|---|---|
| Peripheral blood | ||||||||
| White blood cells (×109/L) | 125 | 114 | 41 | 72 | 15.9 | 21.1 | 73.1 | 54.8 |
| Eosinophils (×109/L) | 62.3 | 96 | 31.2 | 50 | 6 | 7.9 | 17.5 | 32.3 |
| Basophils (×109/L) | 4.9 | 5.7 | 0.3 | 0.7 | 0.7 | 0.07 | 0 | 2.7 |
| Neutrophils (×109/L) | 24.9 | 5.7 | NS | 14 | 6 | 1.9 | 8.8 | 14.3 |
| Lymphocytes (×109/L) | 6.2 | 4 | NS | 5 | NS | 2.7 | 9.5 | 5.5 |
| Monocytes (×109/L) | 1.3 | 0 | NS | 1.4 | NS | 0.5 | 0 | 0 |
| Hemoglobin (g/dl) | 13.5 | 12 | 13.4 | 11.3 | 12 | 12.1 | 12.3 | 8.9 |
| Platelets (×109/L) | 310 | 320 | 309 | 387 | 259 | 207 | 70 | 313 |
| Blasts (×109/L) | 18.7 | 2 | 0 | 0 | 0.2 | 0 | 36.6 | 0 |
| Bone marrow morphology | ||||||||
| Blasts (%) | 68.5 | 80 | 20 | 19 | 62 | 32 | 78 | 5 |
| Eosinophils (%) | 10.5 | 10 | 32 | 35 | 18 | 24 | 7 | 34 |
| Basophils (%) | 1.5 | 0 | NS | 1 | 0 | 1 | NS | NS |
| Immunophenotypic features | ||||||||
| Immunophenotype (according to EGIL classification) | B-III | B-II | B-III | B-II | B-II | B-II | B-II | B-II |
| Myeloid markers (CD13+, CD33+) | – | – | CD33+ | – | CD33+ | – | NS | – |
Pt, Patient; NS, Not specified.